Validating cancer treatments typically involves preclinical studies followed by multiple phases of clinical trials. Preclinical studies use cell cultures and animal models to assess the treatment's initial safety and efficacy. Clinical trials, conducted in phases I through III, further evaluate the treatment in human subjects to ensure it is safe, effective, and superior to existing therapies.
